Stavros Apostolakis MD, PhD
Stavros Apostolakis MD, PhD
Stavros Apostolakis MD, PhD
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Curriculum Vitae<br />
Of<br />
<strong>Stavros</strong> <strong>Apostolakis</strong> <strong>MD</strong>, <strong>PhD</strong><br />
Lecturer in Cardiology<br />
Democritus University of Thrace<br />
Alexandroupolis 2010<br />
1
PERSONAL DETAILS<br />
Surname:<br />
<strong>Stavros</strong><br />
Forename:<br />
<strong>Apostolakis</strong><br />
Date of birth: 11-10-1974<br />
Place of birth:<br />
Athens<br />
Nationality:<br />
Greek Citizen<br />
Sex:<br />
Male<br />
Marital Status:<br />
Married<br />
Address:<br />
Cardiology Department<br />
Alexandroupolis General Hospital<br />
Dragana Area<br />
68100 Alexandroupolis<br />
Greece<br />
Phone: 00302551030387<br />
Email:<br />
sapostol@med.duth.gr<br />
GMC registration number:7043518<br />
MEDICAL EDUCATION<br />
1993-1999 Graduate student in the faculty of Medicine University of Crete, Heraklion,<br />
Crete, Greece.<br />
Graduated in December 1999.<br />
2003-2007 Postgraduate (<strong>PhD</strong>) student in the faculty of Medicine, University of Crete<br />
Heraklion, Crete, Greece, under the supervision of Professor Demetrios A<br />
Spandidos.<br />
Graduated in July 2007.<br />
<strong>PhD</strong> Thesis:<br />
The role of fractalkine (FKN) and CX3CR1 receptor in atherogenesis in<br />
patients with coronary artery disease, correlation of the disease with<br />
genetic polymorphisms.<br />
2
PROFESSIONAL ACTIVITIES<br />
May 2010-present<br />
Lecturer in Cardiology, in the Department of Cardiology, Democritus<br />
University of Thrace<br />
February 2010-May 2010<br />
Research Fellow, in Haemostasis, Thrombosis and Vascular Biology Unit,<br />
University Department of Medicine, City Hospital, Birmingham, UK<br />
(honorary post).<br />
November 2005-November 2010<br />
Registrar in the Cardiology Department of 417 Army Veterans Hospital.<br />
June 2009– July 2009<br />
Research Fellow, in Haemostasis, Thrombosis and Vascular Biology Unit,<br />
University Department of Medicine, City Hospital, Birmingham, UK<br />
(honorary post).<br />
July 2004-July 2005<br />
SHO in the Diabetic outpatient clinic of Venizeleio General Hospital<br />
Heraklion Crete Greece.<br />
October 2002-July 2004<br />
SHO in Internal Medicine at Venizeleio General Hospital, Heraklion Crete<br />
Greece.<br />
January 2000–March 2002<br />
Three-month clinical practice in the departments of Internal Medicine,<br />
Surgery and Cardiology of General Hospital of Rethymno, Crete,<br />
Greece.<br />
Five-month service in the regional health center of Roustica, Crete<br />
Greece.<br />
Seven-month service in the Intensive Care Unit of General Hospital of<br />
Rethymno, Crete Greece.<br />
May 2002-September 2003<br />
Military service.<br />
3
RESEARCH EXPERIENCE<br />
July 2003-July 2007<br />
July 2007-present<br />
<br />
<br />
<strong>PhD</strong> student in the Laboratory of Clinical Virology faculty of Medicine<br />
University of Crete under the supervision of Professor Demetrios A<br />
Spandidos.<br />
Research associate in the Laboratory of Clinical Virology faculty of<br />
Medicine University of Crete and in the Department of Applied<br />
Biochemistry and Immunology, Institute of Molecular Biology and<br />
Biotechnology, FORTH, Heraklion, Crete, Greece, under the<br />
supervision of Professor Demetrios A Spandidos and Professor Elias<br />
Krambovitis.<br />
GRANTS-AWARDS<br />
8000 € research grant from the Hellenic Cardiological Society for the<br />
research protocol entitled “The role of chemokine CXCL8 (IL-8) and the<br />
chemokine receptors CXCR1 and CXCR2 in the pathogenesis of<br />
coronary artery disease”.(Research grants 2008-2009).<br />
Fellowship of the Αmerican Austrian Foundation (AAF) to attend the<br />
International Seminar “SALZBURG WEILL CORNELL SEMINAR IN<br />
CARDIOLOGY” 19-25 April 2009.<br />
12000 € Scholarship from the Hellenic Cardiological Society for further<br />
training in Cardiology in the United Kingdome (2009-2010 HCS<br />
Scholarships).<br />
50000 € Scholarship from the European Society of Cardiology (2010-<br />
2011 Atherothrombosis Research Grant).<br />
4
MEMBER OF SCIENTIFIC SOCIETIES<br />
<br />
<br />
<br />
Member of the Hellenic Cardiological Society.<br />
Member of the Hellenic Diabetes Association.<br />
Member of the National workgroup “Diabetes and Heart disease” of<br />
the Hellenic Diabetes Association.<br />
5
PUBLICATIONS and CONGRESS PRESENTATIONS<br />
32 congress presentations in National Medical Congresses<br />
2 publications in national peer reviewed journals<br />
Presentations in international congresses<br />
1. Lydakis C, Basta M, Prokopiadou D, <strong>Apostolakis</strong> S, Karvunaris S, Karalis I, Seliniotaki E.<br />
Association of obstructive sleep apnea syndrome severity with hypertension. 13 th European Meeting<br />
on Hypertension, Milan, 2003, J Hypertension 2003, 21: S56-S56.<br />
2. <strong>Apostolakis</strong> S, Komis G, Lydataki N, Tzortzakakis E, Zidianakis M. Changes in ischemic stroke<br />
hospital admissions within the last decade. 7 th Mediterranean Medical Congress, Vilamura Portugal,<br />
2003.<br />
3. Lydakis C, <strong>Apostolakis</strong> S, Karalis J, Komis G, Lydataki N, Tzotzakakis E. CPK, CPK MB, and<br />
Troponin I levels in patients with ischemic cerebrovascular accidents. 7 th Mediterranean Medical<br />
Congress, Vilamura Portugal 2003.<br />
4. Lydakis C, <strong>Apostolakis</strong> S, Komis G, Karalis J, Karvounaris S, Lydataki N, Tzotzakakis E.<br />
Association of haemostatic inflammatory factors and lipoproteins with the 6-months outcome in<br />
patients with ischemic stroke. 7 th Mediterranean Medical Congress, Vilamura Portugal 2003.<br />
5. Lydakis C, Tzinas J, <strong>Apostolakis</strong> S, Thalassinos E, Athousakis E, Haritaki E, Seliniotaki E,<br />
<strong>Apostolakis</strong> T. Evaluation of factors contributing to loss of follow up in hypertension. 14 th European<br />
Meeting on Hypertension, Paris 2004, J Hypertension, 2004; 22: S398-S398.<br />
6. <strong>Apostolakis</strong> S, Baritaki S, Krabovitis E, Spandidos DA. Frequencies of HIV/AIDS protective<br />
mutations in SDF-1 Chemokine and CC Chemokine-Receptors gene within the Cretan population. 9 th<br />
World Congress on Advances in Oncology and 7 th International Symposium on Molecular Medicine,<br />
Crete 2004, Ιnt J Μol Μed, 2004; 14: S50-S50 Suppl 1.<br />
7. <strong>Apostolakis</strong> S, Kochiadakis G, Baritaki S, Igoumenidis NE, Skalidis E, Hamilos M,<br />
Panoutsopoulos D, Spandidos DA. 280M variant of CX3C receptor 1 gene is associated with reduced<br />
risk for coronary artery disease. ESC congress Stockholm 2005.<br />
8. Amanatidou V, Sourvinos G, <strong>Apostolakis</strong> S, Tsilimigaki A, and Spandidos DA. T280M variation<br />
of the CX3C receptor gene is associated with increased risk for sever respiratory syncytial virus<br />
bronchiolitis. 10 th World Congress on Advances in Oncology and 8 th International Symposium on<br />
Molecular Medicine, Crete 2005, Int J Mol Med, 2005; 16: S55.<br />
9. <strong>Apostolakis</strong> S, Baritaki S, Kochiadakis GE, Igoumenidis E, Panutsopulos D and Spandidos DA.<br />
280M variation of CX3C receptor 1 gene is associated with lower prevalence and decreased<br />
6
angiographic severity of coronary artery disease. 10 th World Congress on Advances in Oncology and<br />
8 th International Symposium on Molecular Medicine, Crete 2005, Int J Mol Med, 2005; 16: S59.<br />
10. Thalassinos E, Lydakis C, Xaritaki E, <strong>Apostolakis</strong> S, Passam A, Krasanaki A, Athousakis E,<br />
Mihou E. Change in lipid levels after acute ischemic stroke. 9 th Congress of the European Federation of<br />
Neurological Societies (EFNS) Athens 2005.<br />
11. Baritaki S, Kanellou P, <strong>Apostolakis</strong> S, Spandidos DA, Bonavida B. Role of plasma membrane<br />
fluidity alterations in tumor cell sensitization to apoptosis-inducing stimuli: Therapeutic implications.<br />
7 th AACR Annual Meeting, Washington DC 2006.<br />
12. Zidianakis M, <strong>Apostolakis</strong> S, Tzinas I, Thalassinos E, Athousakis E, Lydakis C, Lydataki N,<br />
<strong>Apostolakis</strong> T. Community acquired pneumonia in the elderly. 11 th Conference of the European<br />
Society of Clinical Practice/Family Medicine, Kos 2005.<br />
13. Amanatidou V, Sourvinos G, <strong>Apostolakis</strong> S, Neonaki P, Tsilimigaki A, and Spandidos DA.<br />
RANTES promoter gene polymorphisms and susceptibility to RSV induced bronchiolitis. 11 th World<br />
Congress on Advances in Oncology and 9 th International Symposium on Molecular Medicine, Crete<br />
2006, Int J Mol Med 2006; 18: S77.<br />
14. <strong>Apostolakis</strong> S, Vlata Z, Kochiadakis GE, Baritaki S, Krambovitis E, Spandidos DA. Effects of<br />
angiotensin converting enzyme inhibitors on the chemokine receptors of THP-1 cells. 11 th World<br />
Congress on Advances in Oncology and 9 th International Symposium on Molecular Medicine, Crete<br />
2006, Int J Mol Med 2006; 18: S78.<br />
15. Amanatidou V, Sourvinos G, <strong>Apostolakis</strong> S, Neonaki P, Tsilimigaki A, Spandidos DA.<br />
Implication of RANTES in the pathogenesis of RSV bronchiolitis. A view through population genetics.<br />
25 th International Congress of Pediatrics, Athens 2007.<br />
16. Krambovitis E, <strong>Apostolakis</strong> S, Vlata Z, Spandidos DA. Angiotensins and chemokine receptor<br />
profile of human monocytes. 12 th World Congress on Advances in Oncology and 10 th International<br />
Symposium on Molecular Medicine, Crete 2007, Int J Mol Med 2007; 20: S78.<br />
17. Vogiatzi K, <strong>Apostolakis</strong> S, Kochiadakis GE, Spandidos DA. Interleukin 8 gene polymorphisms<br />
and susceptibility to coronary artery disease. A view through population genetics. 12 th World<br />
Congress on Advances in Oncology and 10 th International Symposium on Molecular Medicine, Crete<br />
2007, Int J Mol Med 2007; 20: S77.<br />
18. Vogiatzi K, Voudris V, <strong>Apostolakis</strong> S, Zaravinos A, Thomopoulou S, Kochiadakis GE, Spandidos<br />
DA. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and<br />
restenosis. 13 th World Congress on Advances in Oncology and 11 th International Symposium on<br />
Molecular Medicine, Crete 2008, Int J Mol Med 2008; 22: S89.<br />
19. Vogiatzi K, Voudris V, <strong>Apostolakis</strong> S, Kochiadakis GE, Thomopoulou S, Zaravinos A, Arfanakis<br />
DA, Spandidos DA, Vardas PE. RANTES gene promoter polymorphisms and susceptibility to coronary<br />
artery disease and restenosis after percutaneous coronary intervention. ESC congress Barcelona 2009<br />
7
20. Vogiatzi K, <strong>Apostolakis</strong> S, Voudris V, Thomopoulou S, Kochiadakis GE, Arfanakis DA,<br />
Spandidos DA, Vardas PE. Polymorphisms of the interleukin 8 gene and restenosis after percutaneous<br />
coronary intervention. ESC congress Barcelona 2009<br />
21. <strong>Apostolakis</strong> S, Vogiatzi K, Vlata Z, E. Krabovitis, D.A. Spandidos. CXCL8 and vascular<br />
inflammation: Interactions with renin-angiotensin-system mediators and blockers. 15th World<br />
Congress on Advances in Oncology and 13th International Symposium on Molecular Medicine,<br />
Loutraki 2010.<br />
22. <strong>Apostolakis</strong> S, Vogiatzi K, Voudris K, Zaravinos A, Thomopoulou S, Kochiadakis GE, Spandidos<br />
DA. CCL5 and CXCL8 gene polymorphisms and susceptibility to coronary artery disease and restenosis<br />
after percutaneous coronary intervention. 15th World Congress on Advances in Oncology and 13th<br />
International Symposium on Molecular Medicine, Loutraki 2010.<br />
23. Tsapaki A, Zaravinos A, <strong>Apostolakis</strong> S, Vogiatzi K, Voudris K, Kochiadakis GE, Spandidos DA.<br />
Genetic variability of the distal promoter of the ST2 gene in coronary artery disease. 15th World<br />
Congress on Advances in Oncology and 13th International Symposium on Molecular Medicine,<br />
Loutraki 2010.<br />
24. Zaravinos A, Tzoras S, <strong>Apostolakis</strong> S, Lazaridis K, Spandidos DA. Measurement of the plasma<br />
cell-free DNA levels in heart failure using the ß-globin gene as a marker. 15th World Congress on<br />
Advances in Oncology and 13th International Symposium on Molecular Medicine, Loutraki 2010.<br />
25. Papadimitriou K, Soulitzis N, <strong>Apostolakis</strong> S, Spandidos DA. Association of CX3CR1 V249I and<br />
T280M polymorphisms with benign prostatic hyperplasia and prostate cancer. 15th World Congress<br />
on Advances in Oncology and 13th International Symposium on Molecular Medicine, Loutraki 2010.<br />
8
Publications published in international peer reviewed journals<br />
(36 publications in peer reviewed journal cited in PubMed database (either published or Epub ahead<br />
of print, 1 manuscript currently accepted)<br />
1. Lydakis C, <strong>Apostolakis</strong> S, Lydataki N, Tzortzakakis E, Komis G. Stroke complicated<br />
endocarditis with positive lupus anticoagulant. Angiology 2005; 56: 503-506.<br />
2. <strong>Apostolakis</strong> S, Baritaki S, Krambovitis E, Spandidos DA. Distribution of HIV/AIDS protective<br />
SDF-1, CCR5 and CCR2 gene variants within Cretan population. J Clin Virol 2005; 34: 310-314.<br />
3. Lydakis C, <strong>Apostolakis</strong> S, Thalassinos E, Stamataki A, Saridaki A, Basta M. “PIP syndrome”. A<br />
potentially threatening manifestation of a psychiatric disorder. Int J Clin Pract 2005; 59: 612-613.<br />
4. <strong>Apostolakis</strong> S, Chalkiadakis I, Ventouri M, Maraki S, Tsoussis S. Lymphocutaneous<br />
Nocardiosis in a breast cancer patient under treatment with docexatel. The Breast Journal 2005; 11:<br />
469.<br />
5. Lydakis C, Thalassinos E, <strong>Apostolakis</strong> S, Athousakis E, Michou E, Kontopoulou E. Hoarseness as<br />
imminent symptom of aortic aneurysm rupture (Ortner’s syndrome) Int Angiol 2006; 25: 231-233.<br />
6. Tsoussis S, Vourliotaki I, Ekonomidou F, <strong>Apostolakis</strong> S. Capecitabine as an alternative in a<br />
case of fluorouracil- induced photodermatitis. Clin Oncol (R Coll Radiol). 2006; 18:158-159.<br />
7. Amanatidou V, Sourvinos G, <strong>Apostolakis</strong> S, Tsilimigaki A, Spandidos DA. T280M variation of<br />
CX3C receptor gene is associated with increased risk for severe respiratory syncytial virus<br />
bronchiolitis. Ped Inf Dis J 2006; 25: 410-414.<br />
8. <strong>Apostolakis</strong> S, Baritaki S, Kochiadakis GE, Igoumenidis N, Panutsopulos D, Spandidos DA.<br />
Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery<br />
disease. Thromb Res 2006; 119: 63-71.<br />
9. <strong>Apostolakis</strong> S, Papadakis EG, Krambovitis E, Spandidos DA. Chemokines in vascular pathology<br />
(Review) Int J Mol Med 2006; 17: 691-701.<br />
10. Baritaki S, <strong>Apostolakis</strong> S, Kanellou P, Dimanche-Boitrel MT, Spandidos DA and Bonavida B.<br />
Reversal of tumor resistance to apoptotic stimuli by alteration of membrane fluidity: therapeutic<br />
implications. Adv Cancer Res 2007; 98: 149-190.<br />
11. <strong>Apostolakis</strong> S, Krambovitis E, Vlata Z, Kochiadakis GE, Baritaki S, Spandidos DA. CX3CR1<br />
receptor is up-regulated in monocytes of coronary artery diseased patients: Impact of preinflammatory<br />
stimuli and renin-angiotensin system modulators. Thromb Res 2007;121: 387-95.<br />
12. Amanatidou V, Sourvinos G, <strong>Apostolakis</strong> S, Neonaki P, Tsilimigaki A, Krambovitis E, Spandidos<br />
DA. RANTES promoter gene polymorphisms and susceptibility to severe RSV induced bronchiolitis.<br />
Ped Inf Dis J 2008; 27: 38-42.<br />
13. Tsoussis S, Ikonomidou F, Vourliotaki I, Papadaki A, <strong>Apostolakis</strong> S. Clinical burden of terminal<br />
phase in cancer patients. J BUON. 2007; 12: 383-8.<br />
9
14. <strong>Apostolakis</strong> S, Vogiatzi K, Krambovitis E, Spandidos DA IL-1 Cytokines in Cardiovascular<br />
Disease: Diagnostic, Prognostic and Therapeutic Implications. Cardiovasc Hematol Agents Med Chem.<br />
2008; 6: 150-8.<br />
15. Vogiatzi K, <strong>Apostolakis</strong> S, Voudris V, Thomopoulou S, Kochiadakis GE, Spandidos DA.<br />
Interleukin 8 and susceptibility to coronary artery disease: A population genetics perspective. J Clin<br />
Immunol. 2008; 28: 329-35.<br />
16. Xenaki E, Hassoulas J, <strong>Apostolakis</strong> S, Sourvinos G, Spandidos DA. Detection of<br />
Cytomegalovirus in atherosclerotic plaques and non-atherosclerotic arteries. Angiology 2009; 60: 504-<br />
8.<br />
17. Amanatidou V, <strong>Apostolakis</strong> S, Spandidos DA. Genetic diversity of the host and severe RSV<br />
induced lower respiratory tract infection. Ped Inf Dis J 2009; 28: 135-40.<br />
18. Tzortzis S, <strong>Apostolakis</strong> S, Xenakis K, Spiropoulos G, Lazaridis K. Catheter-related septic<br />
thrombophlebitis of the superior vena cava involving the atrial septum: a case report. Cases J 2008,<br />
1:272.<br />
19. Vogiatzi K, Voudris V, <strong>Apostolakis</strong> S, Kochiadakis GE, Thomopoulou S, Zaravinos A and<br />
Spandidos DA. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery<br />
disease and restenosis after percutaneous coronary intervention. Thromb Res 2009; 124: 84-9.<br />
20. <strong>Apostolakis</strong> S, Shantsila E, Lip GY. Evidence guided antiplatelet treatment: Time to move<br />
from bench to bedside. Thromb Res 2009; 124: 649-50.<br />
21. <strong>Apostolakis</strong> S, Amanatidou V, Papadakis EG, Spandidos DA. Genetic diversity of CX3CR1 gene<br />
and coronary artery disease: New insights through a meta-analysis. Atherosclerosis 2009; 207: 8-15.<br />
22. Vogiatzi K, <strong>Apostolakis</strong> S, Voudris V, Thomopoulou S, Kochiadakis GE, Spandidos DA.<br />
Interleukin 8 gene polymorphisms and susceptibility to restenosis after percutaneous coronary<br />
intervention. J Thromb Thrombolysis 2010; 29: 134-40.<br />
23. <strong>Apostolakis</strong> S, Shantsila E, Lip GY. Angiopoietins and Preeclampsia: New perspectives in the<br />
quest for markers Am J Hypertens 2009; 22: 820.<br />
24. <strong>Apostolakis</strong> S, Shantsila E, Lip GY. New anticoagulants for the prevention of Deep Venous<br />
Thrombosis. Time to consider cost effectiveness Pharmacoeconomics (accepted).<br />
25. <strong>Apostolakis</strong> S, Vogiatzi K, Amanatidou V, Spandidos DA. Interleukin 8 and cardiovascular<br />
disease. Cardiovasc Res 2009; 84: 353-60.<br />
26. Antoniades D, <strong>Apostolakis</strong> S, Tzoras S, Lazaridis K. Iatrogenic right coronary artery dissection<br />
distal to a total occlusion. Cases J 2009; 2: 6797.<br />
27. <strong>Apostolakis</strong> S, Shantsila E, Lip GY, Lane DA. Contra: "Anti-platelet therapy is an alternative to<br />
oral anticoagulation for atrial fibrillation". Thromb Haemost 2009; 102:914-5.<br />
28. <strong>Apostolakis</strong> S, Shantsila E, Lip GY. Vascular imaging as a cardiovascular risk stratification tool<br />
in systemic lupus erythematosus. J Rheumatol 2009;36:2141-3.<br />
10
29. <strong>Apostolakis</strong> S, Lip GY, Shantsila E. Monocytes in heart failure: relationship to a deteriorating<br />
immune overreaction or a desperate attempt for tissue repair Cardiovasc Res 2010; 85: 649-60.<br />
30. <strong>Apostolakis</strong> S, Vlata Z, Vogiatzi K, Krambovitis E, Spandidos DA. Angiotensin II up-regulates<br />
CX3CR1 expression in THP-1 monocytes: impact on vascular inflammation and atherogenesis. J<br />
Thromb Thrombolysis 2010; 29: 443-8.<br />
31. Dresios C, <strong>Apostolakis</strong> S, Tzortzis S, Lasaridis K, Gardikiotis A. Apical hypertrophic<br />
cardiomyopathy associated with multiple coronary artery-left ventricular fistulae. A report of a case<br />
and review of the literature. Eur J Echocrdiography 2010; 11: E9.<br />
32. <strong>Apostolakis</strong> S, Lip GYH, Lane DA, Shantsila E. The quest for new anticoagulants: From clinical<br />
development to clinical practice. Cardiovasc Ther 2010 [Epub ahead of print].<br />
33. <strong>Apostolakis</strong> S, Amanatidou V, Spandidos DA. Therapeutic implications of chemokinemediated<br />
pathways in atherosclerosis: realistic perspectives and utopias. Acta Pharmacol Sin 2010;<br />
31: 1103-10.<br />
34. Tsarouhas K, Soufla G, <strong>Apostolakis</strong> S, Zaravinos A, Panagiotou M, Khoury M, Hassoulas JA,<br />
Tsatsakis AM, Spandidos DA. Transcriptional regulation of TIMPs in ascending aorta aneurysms.<br />
Thromb Res. 2010 [Epub ahead of print]<br />
35. Tsapaki A, Zaravinos A, <strong>Apostolakis</strong> S, Voudris K, Vogiatzi K, Kochiadakis GE, Spandidos DA.<br />
Genetic variability of the distal promoter of the ST2 gene is associated with angiographic severity of<br />
coronary artery disease. J Thromb Thrombolysis. 2010; 30: 365-71.<br />
36. Zaravinos A, Tzoras S, <strong>Apostolakis</strong> S, Lazaridis K, Spandidos DA. Levosimendan reduces plasma cell<br />
free DNA levels in patients with ischemic cardiomyopathy. J Thromb Thrombolysis 2010 accepted.<br />
11
Curricu<br />
lum<br />
Vitae<br />
OTHER SCIENTIFIC ACTIVITIES<br />
<br />
<br />
Member of the organizing committee of the annual World Congress<br />
on Advances in Oncology and the anual International Symposium on<br />
Molecular Medicine since 2004.<br />
Invited reviewer of the International Journal of Cardiology, the<br />
International Journal of Molecular Medicine, the American Journal of<br />
Hypertension and the Thrombosis Research Journal.<br />
12